Coherus Biosciences, Inc. (CHRS) Stock Steadily Rising in Premarket, Here’s Why
Coherus Biosciences, Inc. (CHRS), a biopharmaceutical company, has gained an increase of 1.56% in premarket trading session. Consequently, CHRS stock is trading at $16.90 at the time of the writing. The increase could be attributed to the announcement of new employment inducement grants. On Thursday, CHRS closed the day at $16.64 after declining 3.20% during […]
